Zacks排名
Search documents
Nabors Industries (NBR) Reports Q2 Loss, Tops Revenue Estimates
ZACKS· 2025-07-29 22:55
Core Viewpoint - Nabors Industries reported a quarterly loss of $2.71 per share, which was worse than the Zacks Consensus Estimate of a loss of $2.05, but an improvement from a loss of $4.29 per share a year ago [1] Financial Performance - The company posted revenues of $832.79 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 0.18% and showing an increase from $734.8 million in the same quarter last year [2] - Over the last four quarters, Nabors has not surpassed consensus EPS estimates, indicating ongoing challenges in meeting market expectations [2] Stock Performance - Nabors shares have declined approximately 38.3% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), suggesting it is expected to underperform the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$2.00 on revenues of $845.35 million, and for the current fiscal year, it is -$3.53 on revenues of $3.27 billion [7] - The trend of estimate revisions for Nabors has been unfavorable leading up to the earnings release, which may impact future stock performance [6] Industry Context - The Oil and Gas - Drilling industry, to which Nabors belongs, is currently ranked in the bottom 5% of over 250 Zacks industries, indicating a challenging environment for companies in this sector [8]
TriMas (TRS) Beats Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-29 14:10
Company Performance - TriMas reported quarterly earnings of $0.61 per share, exceeding the Zacks Consensus Estimate of $0.50 per share, and up from $0.43 per share a year ago, indicating a positive earnings surprise of +22.00% [1][2] - The company achieved revenues of $274.76 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 8.93%, compared to $240.5 million in the same quarter last year [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.52 on revenues of $257.51 million, and for the current fiscal year, it is $1.81 on revenues of $980.07 million [8] - The estimate revisions trend for TriMas was unfavorable prior to the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [7] Industry Context - TriMas operates within the Zacks Metal Products - Procurement and Fabrication industry, which is currently ranked in the bottom 30% of over 250 Zacks industries, suggesting potential challenges ahead [9] - The performance of TriMas may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [9]
Commvault Systems (CVLT) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-07-29 13:56
Core Insights - Commvault Systems (CVLT) reported quarterly earnings of $1.01 per share, exceeding the Zacks Consensus Estimate of $0.97 per share, and up from $0.85 per share a year ago, representing an earnings surprise of +4.12% [1] - The company achieved revenues of $281.98 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.96%, compared to $224.67 million in the same quarter last year [2] - Commvault has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.96 on revenues of $272.17 million, while for the current fiscal year, the estimate is $4.14 on revenues of $1.14 billion [7] - The favorable trend in estimate revisions prior to the earnings release has resulted in a Zacks Rank 1 (Strong Buy) for Commvault, suggesting expected outperformance in the near future [6] Industry Context - The Computer - Software industry, to which Commvault belongs, is currently ranked in the top 19% of over 250 Zacks industries, indicating a positive outlook for stocks within this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Sierra Bancorp (BSRR) Beats Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-28 14:11
Core Insights - Sierra Bancorp reported quarterly earnings of $0.78 per share, exceeding the Zacks Consensus Estimate of $0.74 per share, and showing an increase from $0.71 per share a year ago, resulting in an earnings surprise of +5.41% [1] - The company achieved revenues of $39.21 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.23% and up from $37.8 million year-over-year [2] - The stock has gained approximately 5.5% since the beginning of the year, while the S&P 500 has increased by 8.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $39.1 million, and for the current fiscal year, it is $2.95 on revenues of $153.7 million [7] - The estimate revisions trend for Sierra Bancorp was favorable prior to the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Banks - West industry, to which Sierra Bancorp belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]
Booz Allen Hamilton (BAH) Surpasses Q1 Earnings Estimates
ZACKS· 2025-07-25 12:56
Group 1: Earnings Performance - Booz Allen Hamilton reported quarterly earnings of $1.48 per share, exceeding the Zacks Consensus Estimate of $1.46 per share, and up from $1.38 per share a year ago, representing an earnings surprise of +1.37% [1] - The company posted revenues of $2.92 billion for the quarter ended June 2025, which was below the Zacks Consensus Estimate by 0.54%, and a decrease from year-ago revenues of $2.94 billion [2] - Over the last four quarters, Booz Allen has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Group 2: Stock Performance and Outlook - Booz Allen shares have declined approximately 10.6% since the beginning of the year, contrasting with the S&P 500's gain of 8.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.60 on revenues of $3.06 billion, and for the current fiscal year, it is $6.39 on revenues of $12.24 billion [7] Group 3: Industry Context - The Consulting Services industry, to which Booz Allen belongs, is currently ranked in the top 41% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Booz Allen was unfavorable ahead of the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [6]
First Savings Financial (FSFG) Q3 Earnings and Revenues Top Estimates
ZACKS· 2025-07-25 01:26
分组1 - First Savings Financial (FSFG) reported quarterly earnings of $0.81 per share, exceeding the Zacks Consensus Estimate of $0.72 per share, and up from $0.52 per share a year ago, representing an earnings surprise of +12.50% [1] - The company posted revenues of $21.25 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.17%, compared to year-ago revenues of $17.73 million [2] - Over the last four quarters, First Savings Financial has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 1.9% since the beginning of the year, while the S&P 500 gained 8.1% [3] - The current consensus EPS estimate for the coming quarter is $0.80 on $21.2 million in revenues, and for the current fiscal year, it is $2.90 on $79.1 million in revenues [7] - The Zacks Industry Rank for Financial - Savings and Loan is currently in the bottom 26% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Civista Bancshares (CIVB) Q2 Earnings and Revenues Lag Estimates
ZACKS· 2025-07-24 14:05
Group 1: Earnings Performance - Civista Bancshares reported quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.69 per share, but showing an increase from $0.45 per share a year ago, representing an earnings surprise of -4.35% [1] - The company posted revenues of $41.4 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.37%, compared to year-ago revenues of $38.29 million [2] Group 2: Stock Performance and Outlook - Civista Bancshares shares have increased by approximately 1.7% since the beginning of the year, while the S&P 500 has gained 8.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $43.66 million, and for the current fiscal year, it is $2.81 on revenues of $170.47 million [7] Group 3: Industry Context - The Zacks Industry Rank for Banks - Midwest is currently in the top 29% of over 250 Zacks industries, indicating that the industry is performing relatively well [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that the outlook for the industry can significantly impact stock performance [5][8]
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
ZACKS· 2025-06-20 16:36
Company Overview - Medtronic shares have increased by approximately 6% over the past month, outperforming the S&P 500 index [1] - The most recent earnings report is crucial for understanding the catalysts affecting the stock [1] Earnings Estimates - Estimates for Medtronic have trended downward, with a consensus estimate shift of -6.38% in the past month [2] - The overall direction of estimate revisions indicates a negative outlook for the stock [4] VGM Scores - Medtronic has a Growth Score of B, a Momentum Score of F, and a Value Score of C, resulting in an aggregate VGM Score of C [3] Market Outlook - The downward trend in estimates has led to a Zacks Rank of 4 (Sell) for Medtronic, suggesting expectations of below-average returns in the coming months [4] Industry Comparison - Medtronic is part of the Zacks Medical - Products industry, where Phibro Animal Health (PAHC) has gained 4.1% over the past month [5] - Phibro reported revenues of $347.8 million for the last quarter, reflecting a year-over-year increase of +32.1% [5] - Phibro's expected earnings for the current quarter are $0.52 per share, indicating a +26.8% change from the previous year, with a Zacks Rank of 1 (Strong Buy) [6]
Bears are Losing Control Over Molina (MOH), Here's Why It's a 'Buy' Now
ZACKS· 2025-06-13 14:56
Core Viewpoint - Molina (MOH) shares have recently declined by 6.5% over the past four weeks, but the formation of a hammer chart pattern suggests potential support and a possible trend reversal in the future [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottoming out, with reduced selling pressure, and is a bullish signal for the stock [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, suggesting that buyers are starting to emerge after a downtrend [4][5]. - The occurrence of this pattern at the bottom of a downtrend signals that bears may be losing control, indicating a potential trend reversal [5]. Fundamental Analysis - There has been a positive trend in earnings estimate revisions for Molina, which is a bullish indicator and suggests potential price appreciation [7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 0.1%, indicating that analysts expect better earnings than previously predicted [8]. - Molina currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
ZACKS· 2025-06-12 14:56
Core Viewpoint - P3 Health Partners Inc. (PIII) has experienced a bearish trend with a 13.1% stock price decline over the past two weeks, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottom in the stock price, suggesting that selling pressure may be exhausting and that bulls could be gaining control [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, typically occurring during a downtrend, signaling a possible reversal if it appears at the bottom of the trend [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength is dependent on its placement on the chart [6]. Fundamental Analysis - There has been a positive trend in earnings estimate revisions for PIII, with a 7.8% increase in the consensus EPS estimate for the current year over the last 30 days, indicating that analysts expect better earnings than previously predicted [7][8]. - PIII holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10]. - The Zacks Rank serves as a timing indicator, suggesting that the company's prospects are improving, further supporting the potential for a turnaround in PIII's stock performance [10].